Login
Navigate Fool.com
Will CARA beat
the market?

CARA THERAPEUTICS

NASDAQ: CARA

Community Rating: 5 Stars: The Best

13.82 -1.66 (-10.72%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.61
Previous Close $15.48
Daily Range $13.67 - $15.70
52-Week Range $10.40 - $23.25
Market Cap $312.2M
P/E Ratio -20.92
Dividend (Yield) $0.00 (0.0%)
Volume 201,630
Average Daily Volume 272,089
Current FY EPS -$0.94

How do you think CARA
will perform against the market?

Top CARA Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Stocks: Insiders Buy at 4 Biotechs -- Dicerna, Ultragenyx, Regulus, and Cara

Regulus Therapeutics renewed its strategic alliance with French pharmaceutical company Sanofi, which added $10 million in equity to its stake in the firm.

US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs

See More CARA News...

Sector

Industry

CARA THERAPEUTICS (CARA) Description

CARA THERAPEUTICS Website: http://www.caratherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks